186 related articles for article (PubMed ID: 17320083)
21. Destabilization of Krüppel-like factor 4 protein in response to serum stimulation involves the ubiquitin-proteasome pathway.
Chen ZY; Wang X; Zhou Y; Offner G; Tseng CC
Cancer Res; 2005 Nov; 65(22):10394-400. PubMed ID: 16288030
[TBL] [Abstract][Full Text] [Related]
22. TGF-β synergizes with ML264 to block IL-1β-induced matrix degradation mediated by Krüppel-like factor 5 in the nucleus pulposus.
Xie Z; Jie Z; Wang G; Sun X; Tang P; Chen S; Qin A; Wang J; Fan S
Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):579-589. PubMed ID: 29196238
[TBL] [Abstract][Full Text] [Related]
23. Ubiquitin-mediated regulation of TNFR1 signaling.
Wertz IE; Dixit VM
Cytokine Growth Factor Rev; 2008; 19(3-4):313-24. PubMed ID: 18515172
[TBL] [Abstract][Full Text] [Related]
24. Curcumin promotes KLF5 proteasome degradation through downregulating YAP/TAZ in bladder cancer cells.
Gao Y; Shi Q; Xu S; Du C; Liang L; Wu K; Wang K; Wang X; Chang LS; He D; Guo P
Int J Mol Sci; 2014 Aug; 15(9):15173-87. PubMed ID: 25170806
[TBL] [Abstract][Full Text] [Related]
25. Ubiquitin-dependent and -independent proteasomal degradation of hepatitis B virus X protein.
Kim JH; Sohn SY; Benedict Yen TS; Ahn BY
Biochem Biophys Res Commun; 2008 Feb; 366(4):1036-42. PubMed ID: 18155658
[TBL] [Abstract][Full Text] [Related]
26. α-Catulin promotes cancer stemness by antagonizing WWP1-mediated KLF5 degradation in lung cancer.
Tung CH; Huang MF; Liang CH; Wu YY; Wu JE; Hsu CL; Chen YL; Hong TM
Theranostics; 2022; 12(3):1173-1186. PubMed ID: 35154481
[No Abstract] [Full Text] [Related]
27. Ubiquitin binding modulates IAP antagonist-stimulated proteasomal degradation of c-IAP1 and c-IAP2(1).
Blankenship JW; Varfolomeev E; Goncharov T; Fedorova AV; Kirkpatrick DS; Izrael-Tomasevic A; Phu L; Arnott D; Aghajan M; Zobel K; Bazan JF; Fairbrother WJ; Deshayes K; Vucic D
Biochem J; 2009 Jan; 417(1):149-60. PubMed ID: 18939944
[TBL] [Abstract][Full Text] [Related]
28. Regulation of Krüppel-like factor 4 by the anaphase promoting complex pathway is involved in TGF-beta signaling.
Hu D; Wan Y
J Biol Chem; 2011 Mar; 286(9):6890-901. PubMed ID: 21177849
[TBL] [Abstract][Full Text] [Related]
29. FBW7-mediated ubiquitination and degradation of KLF5.
Luan Y; Wang P
World J Biol Chem; 2014 May; 5(2):216-23. PubMed ID: 24921010
[TBL] [Abstract][Full Text] [Related]
30. Ubiquitin-dependent and ubiquitin-independent control of subunit stoichiometry in the SWI/SNF complex.
Keppler BR; Archer TK
J Biol Chem; 2010 Nov; 285(46):35665-74. PubMed ID: 20829358
[TBL] [Abstract][Full Text] [Related]
31. Regulation of Sprouty2 stability by mammalian Seven-in-Absentia homolog 2.
Nadeau RJ; Toher JL; Yang X; Kovalenko D; Friesel R
J Cell Biochem; 2007 Jan; 100(1):151-60. PubMed ID: 16888801
[TBL] [Abstract][Full Text] [Related]
32. A novel N-terminal hydrophobic motif mediates constitutive degradation of serum- and glucocorticoid-induced kinase-1 by the ubiquitin-proteasome pathway.
Bogusz AM; Brickley DR; Pew T; Conzen SD
FEBS J; 2006 Jul; 273(13):2913-28. PubMed ID: 16817852
[TBL] [Abstract][Full Text] [Related]
33. CHIP (carboxyl terminus of Hsc70-interacting protein) promotes basal and geldanamycin-induced degradation of estrogen receptor-alpha.
Fan M; Park A; Nephew KP
Mol Endocrinol; 2005 Dec; 19(12):2901-14. PubMed ID: 16037132
[TBL] [Abstract][Full Text] [Related]
34. N-Terminal ubiquitination of extracellular signal-regulated kinase 3 and p21 directs their degradation by the proteasome.
Coulombe P; Rodier G; Bonneil E; Thibault P; Meloche S
Mol Cell Biol; 2004 Jul; 24(14):6140-50. PubMed ID: 15226418
[TBL] [Abstract][Full Text] [Related]
35. Role of the IRF-1 enhancer domain in signalling polyubiquitination and degradation.
Pion E; Narayan V; Eckert M; Ball KL
Cell Signal; 2009 Oct; 21(10):1479-87. PubMed ID: 19450680
[TBL] [Abstract][Full Text] [Related]
36. TGF-β causes Docetaxel resistance in Prostate Cancer via the induction of Bcl-2 by acetylated KLF5 and Protein Stabilization.
Li Y; Zhang B; Xiang L; Xia S; Kucuk O; Deng X; Boise LH; Dong JT
Theranostics; 2020; 10(17):7656-7670. PubMed ID: 32685011
[TBL] [Abstract][Full Text] [Related]
37. REGgamma proteasome mediates degradation of the ubiquitin ligase Smurf1.
Nie J; Wu M; Wang J; Xing G; He F; Zhang L
FEBS Lett; 2010 Jul; 584(14):3021-7. PubMed ID: 20580715
[TBL] [Abstract][Full Text] [Related]
38. Ligand-dependent switching of ubiquitin-proteasome pathways for estrogen receptor.
Tateishi Y; Kawabe Y; Chiba T; Murata S; Ichikawa K; Murayama A; Tanaka K; Baba T; Kato S; Yanagisawa J
EMBO J; 2004 Dec; 23(24):4813-23. PubMed ID: 15538384
[TBL] [Abstract][Full Text] [Related]
39. Wwp2-mediated ubiquitination of the RNA polymerase II large subunit in mouse embryonic pluripotent stem cells.
Li H; Zhang Z; Wang B; Zhang J; Zhao Y; Jin Y
Mol Cell Biol; 2007 Aug; 27(15):5296-305. PubMed ID: 17526739
[TBL] [Abstract][Full Text] [Related]
40. N-terminal polyubiquitination and degradation of the Arf tumor suppressor.
Kuo ML; den Besten W; Bertwistle D; Roussel MF; Sherr CJ
Genes Dev; 2004 Aug; 18(15):1862-74. PubMed ID: 15289458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
